Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies

M.D. de Jong; C.A.B. Boucher; D.A. Cooper; G.J. Galasso; B. Gazzard; J.M.A. Lange

Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies

Translated title of the contribution: Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies

M.D. de Jong, C.A.B. Boucher, D.A. Cooper, G.J. Galasso, B. Gazzard, J.M.A. Lange

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies
Original language	Undefined/Unknown
Pages (from-to)	65-82
Number of pages	18
Journal	Antiviral Research
Volume	35
Publication status	Published - 1997

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Algemeen onderzoek
Immunology

Cite this

@article{f6033c6e0b7743f0b6d073496a6538d8,

title = "Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Algemeen onderzoek, Immunology",

author = "{de Jong}, M.D. and C.A.B. Boucher and D.A. Cooper and G.J. Galasso and B. Gazzard and J.M.A. Lange",

year = "1997",

language = "Undefined/Unknown",

volume = "35",

pages = "65--82",

journal = "Antiviral Research",

issn = "0166-3542",

publisher = "Elsevier",

}

TY - JOUR

T1 - Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies

AU - de Jong, M.D.

AU - Boucher, C.A.B.

AU - Cooper, D.A.

AU - Galasso, G.J.

AU - Gazzard, B.

AU - Lange, J.M.A.

PY - 1997

Y1 - 1997

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Algemeen onderzoek

KW - Immunology

M3 - Article

SN - 0166-3542

VL - 35

SP - 65

EP - 82

JO - Antiviral Research

JF - Antiviral Research

ER -